BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2874464)

  • 21. Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.
    Brogden RN; Carmine AA; Heel RC; Speight TM; Avery GS
    Drugs; 1982 Oct; 24(4):267-303. PubMed ID: 6128216
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ranitidine reverses cimetidine-induced mental confusion in a patient with Zollinger-Ellison syndrome.
    Pedrazzoli S; Petrin P; Pasquali C; Militello C; Sperti C; Fregonese V; Simini G
    Arch Surg; 1983 Feb; 118(2):256. PubMed ID: 6295340
    [No Abstract]   [Full Text] [Related]  

  • 23. Famotidine: effective treatment of Zollinger-Ellison syndrome.
    Howard JM; Vinayek R; Maton PN; Wank SA; Gardner JD; Jensen RT
    J Clin Gastroenterol; 1987; 9 Suppl 2():23-5. PubMed ID: 2887615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome.
    Campoli-Richards DM; Clissold SP
    Drugs; 1986 Sep; 32(3):197-221. PubMed ID: 2875864
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cimetidine: a review (author's transl)].
    Hoffenberg P
    Rev Med Chil; 1979 Mar; 107(3):245-50. PubMed ID: 38497
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug usage evaluation: H2-receptor antagonist use in 30 hospitals.
    Kowalsky SF; Hamilton RA; Figge HL
    Hosp Formul; 1991 Sep; 26(9):725-6, 732, 734-6 passim. PubMed ID: 10114004
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do H2 receptor antagonists have a therapeutic role in childhood?
    Kelly DA
    J Pediatr Gastroenterol Nutr; 1994 Oct; 19(3):270-6. PubMed ID: 7815256
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Review of histamine H2 receptor antagonists].
    GarcĂ­a Plaza A; Pascasio Acevedo JM
    Rev Esp Enferm Apar Dig; 1984 Oct; 66(4):288-94. PubMed ID: 6151218
    [No Abstract]   [Full Text] [Related]  

  • 30. Histamine H2-receptor antagonists and gastric acid secretion.
    Pounder RE
    Pharmacol Ther; 1984; 26(2):221-34. PubMed ID: 6152495
    [No Abstract]   [Full Text] [Related]  

  • 31. Famotidine in the therapy of gastric hypersecretory states.
    Vinayek R; Howard JM; Maton PN; Wank SA; Slaff JI; Gardner JD; Jensen RT
    Am J Med; 1986 Oct; 81(4B):49-59. PubMed ID: 2877575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cimetidine: clinical uses and possible side effects.
    Babb RR
    Postgrad Med; 1980 Dec; 68(6):87-93. PubMed ID: 6968898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. H2 receptor antagonists.
    Siepler JK; Campagna KD; Donahue PE; Bombeck CT
    Am J Hosp Pharm; 1978 Feb; 35(2):141-5. PubMed ID: 24338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [H2 antagonists and the heart].
    Corradini P; Zocchi M; Buonavia A
    Minerva Med; 1986 Dec; 77(47-48):2209-15. PubMed ID: 2880317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of H2-receptor antagonists in children.
    Dimand RJ
    DICP; 1990 Nov; 24(11 Suppl):S42-6. PubMed ID: 2270695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacology and clinical efficacy of ranitidine, a new H2-receptor antagonist.
    Helman CA; Tim LO
    Pharmacotherapy; 1983; 3(4):185-92. PubMed ID: 6136952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Histamine H2 receptor blockaders: possibilities and prognosis in the use of stage III-IV preparations in the therapy of internal diseases].
    Miagkova LP; Grebenev AL; Kkhorshed AM
    Klin Med (Mosk); 1991 Mar; 69(3):27-34. PubMed ID: 1676773
    [No Abstract]   [Full Text] [Related]  

  • 38. [The therapeutic importance of cimetidine (Tagamet) (author's transl)].
    Voget E; Schollmeyer P
    MMW Munch Med Wochenschr; 1978 Nov; 120(44):1467-72. PubMed ID: 81467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neuropsychic effects of cimetidine and ranitidine. Apropos of 1 case].
    Ducluzeau R; Vial T; Pobel D; Descotes J
    J Toxicol Clin Exp; 1990; 10(1):37-9. PubMed ID: 2362253
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ranitidine: a new H2-receptor antagonist.
    Zeldis JB; Friedman LS; Isselbacher KJ
    N Engl J Med; 1983 Dec; 309(22):1368-73. PubMed ID: 6314139
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.